WEDNESDAY, Aug. 24 (HealthDay News) -- Botox
(onabotulinumtoxinA) has been approved by the U.S. Food and Drug
Administration to treat urinary incontinence in people with
neurological conditions such as spinal cord injury and multiple
Some people with these conditions have uncontrolled bladder
contractions, which leads to inability to retain urine. Common
treatments include medication or a catheter, the agency said in a
The use of Botox involves injecting the drug into the bladder,
relaxing the bladder. The drug's effects last for about nine
months, the FDA said.
Botox was evaluated for this use in clinical studies involving
691 people. The most common adverse reactions included urinary
tract infection and urinary retention.
Botox also is FDA-approved for reducing facial frown lines, and
treating chronic migraine, certain forms of muscle stiffness,
severe underarm sweating and abnormal twitches of the eyelid.
The drug is marketed by Irvine, Calif.-based Allergan Inc.
To learn more about incontinence, visit the U.S.
National Library of Medicine.